Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZALEPLON vs ZANUBRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZALEPLON vs ZANUBRUTINIB: Safety Overview

Metric ZALEPLON ZANUBRUTINIB
Total FAERS Reports 381 2,797
Deaths Reported 100 320
Death Rate 26.2% 11.4%
Hospitalizations 52 806
Average Patient Age 60.4 yrs 71.5 yrs
% Female Patients 66.5% 43.0%
FDA Approval Date Aug 13, 1999 Jun 10, 2025
Manufacturer Hikma Pharmaceuticals USA Inc. BeOne Medicines USA, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued